NYSE · CIK 0000066740 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
3M COMPANY
MMM chart by TradingView
PRICE HISTORY
LIVE · NYSEMMM chart by TradingView
- REVENUE FY2025 ENDED DEC 2025
- $24.9B
- EBITDA
- $5.9B
- FREE CASH FLOW
- $1.4B
- EPS
- $6.00
- GROSS MARGIN
- 39.91%
- ROIC
- —
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET
VALUATION
what you pay for a unit of the business7 CHARTS⤢
P / E RATIO (TTM)
28.2x
+53%8.0x60.1x
⤢
P / SALES (TTM)
3.4x
+11%1.5x3.8x
⤢
P / BOOK
28.7x
+277%3.2x28.7x
⤢
EV / EBITDA (TTM)
—
+6%11.9x12.6x
⤢
EV / REVENUE (TTM)
—
+5%3.4x3.5x
⤢
FCF YIELD (TTM)
4.71%
-1.2pp-2.41%11.18%
⤢
DIVIDEND YIELD (TTM)
1.87%
-1.5pp1.82%7.65%
GROWTH
is the business getting bigger5 CHARTS⤢
REVENUE
$6.5B
-16%⤢
EBITDA (DERIVED)
$1.0B
-49%⤢
NET INCOME
$0.9B
-30%⤢
EPS (DILUTED)
$1.79
-17%⤢
REVENUE GROWTH YOY
2.46%
+2.5pp-99.87%36500.00%
PROFITABILITY & RETURNS
what survives to the bottom, and what it earns on capital4 CHARTS⤢
FCF MARGIN
11.74%
-8.5pp-32.30%12872.73%
⤢
RETURN ON CAPITAL
—
+2.5pp22.37%25.83%
⤢
RETURN ON EQUITY (TTM)
101.52%
+60.4pp-158.37%108.62%
MARGIN FUNNEL
every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the businessGROSS MARGIN41.28%
OPERATING MARGIN15.14%
NET MARGIN14.35%
FCF MARGIN11.74%
CASH & CAPITAL
where the money actually goes5 CHARTS⤢
FREE CASH FLOW
$0.8B
-51%⤢
STOCK-BASED COMP
$0.0B
-20%⤢
CAPITAL EXPENDITURE
$0.2B
-36%⤢
SHARES OUTSTANDING
0.52B
-16%⤢
DIVIDEND / SHARE
$0.78
-43%BALANCE SHEET
how much cushion there is3 CHARTS⤢
CASH & EQUIVALENTS
—
-6%⤢
TOTAL DEBT
$12.6B
+2%⤢
DEBT / EBITDA (TTM)
2.1x
+45%1.3x7.3x
OWNERSHIP
10 LARGEST HOLDERS · WHO OWNS THE FLOATINSTITUTIONS 78.99%INSIDERS 0.10%OTHER / RETAIL 20.91%2,784 INSTITUTIONAL FILERS
| HOLDER | % HELD | SHARES | VALUE | CHANGE |
|---|---|---|---|---|
| JPMORGAN CHASE & CO | 9.00% | 46.4M | $8.49B | +1.9% |
| Blackrock Inc. | 8.27% | 42.7M | $7.80B | +8.9% |
| Vanguard Capital Management LLC | 6.64% | 34.2M | $6.26B | NEW |
| State Street Corporation | 5.38% | 27.7M | $5.07B | -0.5% |
| Geode Capital Management, LLC | 2.31% | 11.9M | $2.18B | +0.9% |
| FMR, LLC | 1.84% | 9.5M | $1.73B | +2.4% |
| Vanguard Portfolio Management LLC | 1.83% | 9.5M | $1.73B | NEW |
| Capital World Investors | 1.78% | 9.2M | $1.68B | -15.3% |
| State Farm Mutual Automobile Insurance Co | 1.54% | 7.9M | $1.45B | +0.0% |
| Morgan Stanley | 1.45% | 7.5M | $1.37B | -8.0% |
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.